This track focuses on the latest innovations in the development of anticancer drugs, highlighting novel compounds and therapeutic strategies. Researchers are invited to present findings that explore mechanisms of action, efficacy, and safety profiles of new agents.

This session will delve into the identification and validation of cancer biomarkers that aid in diagnosis, prognosis, and treatment response. Contributions that discuss the clinical implications of biomarker research in various cancer types are particularly encouraged.

This track showcases cutting-edge technologies and methodologies that are transforming cancer research, including genomics, proteomics, and imaging techniques. Presentations should emphasize how these innovations enhance our understanding of cancer biology and treatment.

This session will explore advancements in clinical laboratory practices that improve cancer diagnosis and monitoring. Topics may include novel diagnostic assays, liquid biopsies, and the integration of laboratory findings into clinical decision-making.

This track addresses the epidemiological aspects of cancer, focusing on risk factors, prevention strategies, and public health initiatives. Researchers are encouraged to present studies that highlight effective interventions and population-based approaches to reduce cancer incidence.

This session will cover the latest developments in chemotherapy and radiotherapy, including combination therapies and personalized treatment approaches. Contributions that discuss the challenges and successes in managing treatment-related toxicities are welcome.